Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App





Lumin UV System Receives FDA EUA for SARS-CoV-2 N95 Re-Use in Nursing Homes, Ambulatory Care and Primary Care

By HospiMedica International staff writers
Posted on 07 Dec 2020
3B Medical, Inc. More...
(Winter Haven, FL, USA) has received Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA) to permit the use of Lumin, a UVC system, on N95 respirators during the COVID-19 pandemic.

Lumin was designed to clean CPAP accessories but is also used as a multi-purpose sanitizer. The EUA by the FDA allows Lumin to be used by healthcare workers employed in nursing homes, long-term acute care, ambulatory, primary care, and clinics to allow N95 re-use to stop the spread of COVID-19 and help keep frontline healthcare workers safe. Lumin is a high powered UVC based sanitizing device, initially developed for home use to clean CPAP accessories in a mirrored chamber. It is lab tested to kill bacteria and viruses, including human coronavirus and influenza, in only five minutes with no chemicals.

The CDC recognizes UVC as a potential means of decontaminating N95 respirators, if the proper wavelength and UVC irradiance dose were used. While FDA has approved other systems for hospital use, the approved systems are complicated, limited to large hospitals and/or extremely expensive. Lumin is the only N95 decontamination system formally recognized by FDA for killing SARS-CoV-2 that can be purchased for under USD 300, and with a small enough footprint to be used safely in small offices and clinics, as well as in nursing homes.

"The COVID-19 global pandemic requires novel approaches and thinking outside the box. We were starting to get inundated with calls from hospitals and nursing homes asking if Lumin was strong enough to kill SARS-CoV-2. Lumin's total output in a single five minute cycle ranges up to 2,400 mJ/cm2, which studies show is sufficient to kill almost any pathogen, including SARS-CoV-2. A lot of the calls coming into our office are from Fire & Rescue departments, nursing homes and smaller community hospitals, clinics and primary care physician offices trying to keep their workers safe. Lumin is likely the only device designed for home use that is powered high enough to repurpose for this use. We are very excited to have our device authorized by FDA for this application," said Alex Lucio, CEO of 3B Medical, Inc.

"Being able to re-use an N95 mask quickly and effortlessly is a game changer for allowing healthcare workers to remain safe. Front line healthcare workers are in dire need of an immediate solution to re-use their masks. Lumin is fast and easy to use and we are glad the device could be re-purposed to meet that need in this crisis," added Lucio.

Related Links:
3B Medical, Inc.


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Endoscopy Display
E190
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.